|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Perz JF, Armstrong GL, Farrington LA,
Hutin YJ and Bell BP: The contributions of hepatitis B virus and
hepatitis C virus infections to cirrhosis and primary liver cancer
worldwide. J Hepatol. 45:529–538. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shin JW and Chung YH: Molecular targeted
therapy for hepatocellular carcinoma: current and future. World J
Gastroenterol. 19:6144–6155. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Trevisani F, Cantarini MC, Wands JR and
Bernardi M: Recent advances in the natural history of
hepatocellular carcinoma. Carcinogenesis. 29:1299–1305. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang Y, Nagano H, Ota H, et al: Patterns
and clinicopathologic features of extrahepatic recurrence of
hepatocellular carcinoma after curative resection. Surgery.
141:196–202. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kruger RP, Aurandt J and Guan KL:
Semaphorins command cells to move. Nat Rev Mol Cell Biol.
6:789–800. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yazdani U and Terman JR: The semaphorins.
Genome Biol. 7:2112006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mann F, Chauvet S and Rougon G:
Semaphorins in development and adult brain: Implication for
neurological diseases. Prog Neurobiol. 82:57–79. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tamagnone L: Emerging role of semaphorins
as major regulatory signals and potential therapeutic targets in
cancer. Cancer Cell. 22:145–152. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tamagnone L, Artigiani S, Chen H, et al:
Plexins are a large family of receptors for transmembrane,
secreted, and GPI-anchored semaphorins in vertebrates. Cell.
99:71–80. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rehman M and Tamagnone L: Semaphorins in
cancer: biological mechanisms and therapeutic approaches. Semin
Cell Dev Biol. 24:179–189. 2013. View Article : Google Scholar
|
|
12
|
Zhou Y, Gunput RA and Pasterkamp RJ:
Semaphorin signaling: progress made and promises ahead. Trends
Biochem Sci. 33:161–170. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sadanandam A, Varney ML and Singh RK:
Identification of semaphorin 5A interacting protein by applying
apriori knowledge and peptide complementarity related to protein
evolution and structure. Genomics Proteomics Bioinformatics.
6:163–174. 2008. View Article : Google Scholar
|
|
14
|
Artigiani S, Conrotto P, Fazzari P, et al:
Plexin-B3 is a functional receptor for semaphorin 5A. EMBO Rep.
5:710–714. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hartwig C, Veske A, Krejcova S,
Rosenberger G and Finckh U: Plexin B3 promotes neurite outgrowth,
interacts homophilically, and interacts with Rin. BMC Neurosci.
6:532005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li X and Lee AY: Semaphorin 5A and
plexin-B3 inhibit human glioma cell motility through
RhoGDIalpha-mediated inactivation of Rac1 GTPase. J Biol Chem.
285:32436–32445. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wong OG, Nitkunan T, Oinuma I, et al:
Plexin-B1 mutations in prostate cancer. Proc Natl Acad Sci USA.
104:19040–19045. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tong Y, Hota PK, Hamaneh MB and Buck M:
Insights into oncogenic mutations of plexin-B1 based on the
solution structure of the Rho GTPase binding domain. Structure.
16:246–258. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Balakrishnan A, Penachioni JY, Lamba S, et
al: Molecular profiling of the ‘plexinome’ in melanoma and
pancreatic cancer. Hum Mutat. 30:1167–1174. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pan GQ, Ren HZ, Zhang SF, Wang XM and Wen
JF: Expression of semaphorin 5A and its receptor plexin B3
contributes to invasion and metastasis of gastric carcinoma. World
J Gastroenterol. 15:2800–2804. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Edmondson HA and Steiner PE: Primary
carcinoma of the liver: a study of 100 cases among 48,900
necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wittekind C: Pitfalls in the
classification of liver tumors. Pathologe. 27:289–293. 2006.(In
German). View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Greene FL, Page DL, Fleming ID, Fritz AG,
Balch CM, Haller DG and Morrow M: TNM classification of Malignant
Tumors. American Joint Committee on Cancer: AJCC Cancer Staging
Manual. 6th ed. Springer; New York, NY: pp. 1332002
|
|
24
|
Casazza A, Fazzari P and Tamagnone L:
Semaphorin signals in cell adhesion and cell migration: functional
role and molecular mechanisms. Adv Exp Med Biol. 600:90–108. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kantor DB, Chivatakarn O, Peer KL, et al:
Semaphorin 5A is a bifunctional axon guidance cue regulated by
heparan and chondroitin sulfate proteoglycans. Neuron. 44:961–975.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pan G, Zhu Z, Huang J, et al: Semaphorin
5A promotes gastric cancer invasion/metastasis via urokinase-type
plasminogen activator/phosphoinositide 3-kinase/protein kinase B.
Dig Dis Sci. 58:2197–2204. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan G, Zhang X, Ren J, et al: Semaphorin
5A, an axon guidance molecule, enhances the invasion and metastasis
of human gastric cancer through activation of MMP9. Pathol Oncol
Res. 19:11–18. 2013. View Article : Google Scholar
|
|
28
|
Sadanandam A, Sidhu SS, Wullschleger S, et
al: Secreted semaphorin 5A suppressed pancreatic tumour burden but
increased metastasis and endothelial cell proliferation. Br J
Cancer. 107:501–507. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sadanandam A, Varney ML, Singh S, et al:
High gene expression of semaphorin 5A in pancreatic cancer is
associated with tumor growth, invasion and metastasis. Int J
Cancer. 127:1373–1383. 2010. View Article : Google Scholar : PubMed/NCBI
|
